NewGenIvf Closes Underwritten Offering Raising About $2.5 Million
NewGenIvf Group has closed its underwritten offering of about $2.5 million gross, priced at $0.035 per Class A share, according to GlobeNewswire.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
NewGenIvf Group Limited said it has closed a firm commitment underwritten offering with gross proceeds of about $2.5 million, before underwriting fees and other expenses, according to GlobeNewswire. The offering included 71,428,570 Class A ordinary shares or pre-funded warrants in their place. At closing, it comprised 9,501,148 shares and warrants plus pre-funded warrants for up to 61,927,422 Class A shares.
The price was $0.035 per share and $0.03499 per pre-funded warrant. The transaction closed on November 20, 2026. The shares trade on the Nasdaq Capital Market under the ticker NIVF, and Aegis Capital Corp. was the sole book-running manager. The company plans to use the proceeds for its Nodexus cytometry technology, assisted reproduction services, prediction-market and digital-asset initiatives, UAE real estate, and about $625,000 to repurchase part of its Exchange Note.
why it matters
For the broader market this is a small, company-specific financing. The main point is dilution: a new share issue at a very low price usually signals limited access to capital for the company.
tags
instruments
sources
- NewGenIvf Group Limited Announces Closing of $2.5 Million Underwritten Offering — globenewswire.com, 20 November 2026 at 14:43 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗